Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.92 USD | -1.16% | -0.67% | +1.47% |
Apr. 25 | Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 24 | Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M | MT |
Financials (USD)
Sales 2024 * | 538M | Sales 2025 * | 579M | Capitalization | 840M |
---|---|---|---|---|---|
Net income 2024 * | 40M | Net income 2025 * | 57M | EV / Sales 2024 * | 1.81 x |
Net Debt 2024 * | 132M | Net Debt 2025 * | 79M | EV / Sales 2025 * | 1.59 x |
P/E ratio 2024 * |
21.5
x | P/E ratio 2025 * |
15
x | Employees | 3,500 |
Yield 2024 * |
0.22% | Yield 2025 * |
0.22% | Free-Float | 98.96% |
Latest transcript on Core Laboratories Inc.
1 day | -1.16% | ||
1 week | -0.67% | ||
Current month | +13.42% | ||
1 month | +8.41% | ||
3 months | +25.31% | ||
6 months | -3.19% | ||
Current year | +1.47% |
Managers | Title | Age | Since |
---|---|---|---|
Lawrence Bruno
CEO | Chief Executive Officer | 64 | - |
Christopher Hill
DFI | Director of Finance/CFO | 54 | - |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Curtis Anastasio
BRD | Director/Board Member | 67 | 23-06-27 |
Director/Board Member | 71 | 19-12-31 | |
Director/Board Member | 74 | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 17.92 | -1.16% | 278,050 |
24-05-23 | 18.13 | -1.57% | 303,684 |
24-05-22 | 18.42 | -2.18% | 368,165 |
24-05-21 | 18.83 | +2.73% | 341,501 |
24-05-20 | 18.33 | +1.61% | 376,517 |
Delayed Quote Nyse, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.47% | 850M | |
+17.04% | 17.52B | |
-18.17% | 2.74B | |
-13.55% | 2.67B | |
-30.18% | 1.82B | |
0.00% | 1.42B | |
-9.39% | 1.13B | |
-10.23% | 1.04B | |
-16.31% | 790M | |
-3.11% | 748M |
- Stock Market
- Equities
- CLB Stock